Frequency of APOE, MTHFR and ACE polymorphisms in the Zambian population

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Atadzhanov, Masharip ^a   Mwaba, Mwila H ^a   Mukomena, Patrice N ^a   Lakhi, Shabir ^a   Mwaba, Peter ^a   Rayaprolu, Sruti ^b   Meschia, James F ^c   Ross, Owen A ^b  

^a UNIVERSITY OF ZAMBIA   (Zambia)

^b MAYO GRADUATE SCHOOL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

ACE polymorphisms; APOE; Frequency; MTHFR; Sub Saharan Africa; Zambia

Indexed keywords

ACE PROTEIN, HUMAN; APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

ADULT; ALLELE; ALZHEIMER DISEASE; BLACK PERSON; CARDIOVASCULAR DISEASE; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; MUTATION RATE; RISK FACTOR; ZAMBIA;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CARDIOVASCULAR DISEASES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION RATE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS; ZAMBIA;

EID: 84898459242     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-194     Document Type: Article

References (78)

1. Burden of stroke in black populations in sub-Saharan Africa. Connor MD, Walker R, Modi G, Warlow CP, Lancet Neurol 2007 6 269 78 10.1016/S1474-4422(07) 70002-9 17303533 (Pubitemid 46228069)
2. Apolipoprotein E genotypes and their relation to lipid levels in a rural South African population Scandinavian. Masemola ML, Alberts M, Urdal P, J Public Health 2007 35 Suppl 69 60 65 (Pubitemid 47241581)
3. Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project. Cross DS, Ivacic LC, Stefanski EL, McCarty CA, BMC Genet 2010 11 51 20565774
4. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC, Am J Epidemiol 2002 155 6 487 495 10.1093/aje/155.6.487 11882522 (Pubitemid 34208040)
5. Apolipoprotein E genotype, cardiovascular risk and responsiveness to dietary fat manipulation. Minihane AM, Jofre-Monseny L, Olano-Martin E, Rimbach G, Proc Nutr Soc 2007 66 2 183 197 10.1017/S0029665107005435 17466101 (Pubitemid 46684972)
6. Genetic polymorphisms for the study of multifactorial stroke. Bersano A, Ballabio E, Bresolin N, Candelise L, Hum Mutat 2008 29 776 795 10.1002/humu.20666 18421701 (Pubitemid 351794129)
7. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta-Analysis Consortium. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM, JAMA 1997 278 1349 1356 10.1001/jama.1997.03550160069041 9343467 (Pubitemid 27449696)
8. An insertion/deletion polymorphism in the angio-tensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F, J Clin Invest 1990 86 1343 1346 CrossRef, PubMed, CSA 10.1172/JCI114844 1976655 (Pubitemid 20370444)
9. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidy 1 carboxypeptidase 1). Rigat B, Hubert C, Corvol P, Soubrier F, Nucleic Acids Res 1992 20 14 33 CrossRef, PubMed
10. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Bonnardeaux A, Davies E, Jeunemaitre X, Féry I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F, Hypertension 1994 24 63 9 10.1161/01.HYP.24.1.63 8021009 (Pubitemid 24195405)
11. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Kee F, Arveiler D, Luc G, Lancet 1994 344 910 3 10.1016/S0140-6736(94)92268-3 7934345 (Pubitemid 24295876)
12. Association between a deletion polymorphism of the angiotensin- converting-enzyme gene and left ventricular hypertrophy. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, Lorell BH, Riegger GA, N Engl J Med 1994 330 1634 8 10.1056/NEJM199406093302302 8177269 (Pubitemid 24166863)
13. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease. Alvarez R, Reguero JR, Batalla A, Iglesias-Cubero G, Cortina A, Alvarez V, Cardiovasc Res 1998 40 375 9 10.1016/S0008-6363(98)00179-5 9893731 (Pubitemid 28506048)
14. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Bøhn M, Berge KE, Bakken A, Erikssen J, Berg K, Clin Genet 1993 44 292 7 8131299
15. Frequencies of the angiotensinogen gene and angiotensin I converting enzyme (ACE) gene polymorphisms in African Americans. Rutledge DR, Browe CS, Ross EA, Biochem Mol Biol Int 1994 34 1271 1275 PubMed, CSA 7696999
16. Evidence for association and genetic linkage of the angiotensin- converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Circulation 1998 97 1766 72 10.1161/01.CIR.97.18.1766 9603529
17. A population study of ethnic variations in the angiotensin converting enzyme I/D polymorphism: relationships with gender, hypertension and impaired glucose metabolism. Sagnella GA, Rothwell MJ, Onipinla AK, Wicks PD, Cook DG, Cappuccio PF, J Hypertens 1999 17 657 664 10.1097/00004872-199917050-00009 10403609 (Pubitemid 29243498)
18. Angiotensin converting enzyme and Alzheimer's disease. Kugaevskaia EV, Biomed Khim 2013 59 1 5 24 23650720
19. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele? Corbo RM, Scacchi R, Ann Hum Genet 1999 63 301 310 10.1046/j.1469-1809.1999.6340301.x 10738542 (Pubitemid 30021229)
20. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Fullerton SM, Clark AG, Weiss KM, Nickerson DA, Taylor SL, Stengard JH, Am J Hum Genet 2000 67 881 900 10.1086/303070 10986041
21. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. Wilson PF, Myers RH, Larson MG, Ordovas JM, Wolf PM, Schaefer EJ, JAMA 1994 27 2 661 71
22. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. Farrer LA, Cupples LA, J Am Med Assoc 1997 27 8 1349 58
23. Age dependence of the influence of methylenetetrahydrofolatereductase genotype on plasma homocysteine level. Spotila LD, Jacques PF, Berger PB, Ballman KV, Ellison RC, Rozen R, Am J Epidemiol 2003 158 9 871 877 10.1093/aje/kwg234 14585765 (Pubitemid 37323249)
24. Moderately elevated plasma homocysteine, MethylenetetrahydrofolateReductase genotype, and risk for stroke vascular dementia, and Alzheimer disease in northern Ireland. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP, Stroke 2002 33 10 2351 6 10.1161/01.STR.0000032550.90046.38 12364720
25. Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolatereductase (MTHFR): findings from over 7000 newborns from 16 areas worldwide. Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, Redlund M, Stoll C, Alembik Y, Dott B, Czeizel AE, Gelman-Kohan Z, Scarano G, Bianca S, Ettore G, Tenconi R, Bellato S, Scala I, Mutchinick OM, López MA, de Walle H, Hofstra R, Joutchenko L, Kavteladze L, Bermejo E, Martínez- Frías ML, Gallagher M, Erickson JD, Vollset SE, Mastroiacovo P, Andria G, et al. J Med Genet 2003 40 619 625 10.1136/jmg.40.8.619 12920077 (Pubitemid 37046918)
26. APOE distribution in world populations with new data from India and the UK. Singh PP, Singh M, Mastana SS, Ann Hum Biol 2006 33 3 279 308 10.1080/03014460600594513 17092867 (Pubitemid 44232589)
27. New World Encyclopedia http://www.newworldencyclopedia.org/entry/Zambia
28. Encyclopedia of the Nations http://www.nationsencyclopedia.com/Africa/ Zambia-HISTORY.html
29. Stroke characteristics and outcomes of adult patients admitted to the University Teaching Hospital, Lusaka, Zambia. Atadzhanov M, Mukomena PN, Lakhi S, Ross OA, Meschia JF, Open Gen Inter Med J 2012 5 3 8 10.2174/ 1874076601205010003
30. Familial aggregation of stroke (Literature review). Mukomena PN, Lakhi S, Mwaba MH, Atadzhanov M, Med J Zambia in Press
31. Reconstruction of human evolution: bringing together genetic, archeological, and linguistic data. Cavalli-Sforza LL, Piazza A, Menozzi P, Mountain J, Proc Natl Acad Sci U S A 1988 85 6002 6006 10.1073/pnas.85.16.6002 3166138
32. Does apolipoprotein E polymorphism influence susceptibility to malaria? Wozniak MA, Faragher EB, Todd JA, Koram KA, Riley EM, Itzhaki RF, J Med Genet 2003 40 348 351 10.1136/jmg.40.5.348 12746397 (Pubitemid 36613472)
33. ApolipoproteinE4 Allele frequency in young Africans of Ugandan descent versus African Americans. Willis F, Graff-Radford N, Martin P, Lawson L, Adamson J, Epstein D, Parfitt F, Hufton M, O'brien PC, J Natl Med Assoc 2003 95 1 12656444
34. Evaluation of risk factors for Alzheimer's disease in elderly east Africans. Kalaria RN, Ogengo'o JA, Patel NB, Sayi JG, Kitinya JN, Chande HM, Matuja WB, Mtui EP, Kimani JK, Premkumar DRD, Koss E, Gateres S, Friedland RP, Elsevier 1997 44 5 573 577 (Pubitemid 27494674)
35. High frequency of the apolipoprotein E*4 allele in African pygmies and most of the African populations in sub-Saharan Africa. Zekraoui L, Lagarde JP, Raisonnier A, Gérard N, Aouizérate A, Lucotte G, Hum Biol 1997 69 4 575 581 9198315 (Pubitemid 27274837)
36. Prevalence of angiotensin-converting enzyme, methylenetetrahydrofolatereductase, Factor V Leiden, prothrombin and apolipoprotein E gene polymorphisms in Morocco. They-They TP, Hamzi K, Moutawafik MT, Bellayou H, Messal M, Nadifi S, Ann Hum Biol 2010 37 6 767 777 10.3109/03014461003738850 20687780
37. Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease. Bahri R, Esteban E, Moral P, Hassine M, Hamda KB, Chaabani H, Lipids Health Dis 2008 7 46 10.1186/1476-511X-7-46 19014618
38. Genetic studies of human apolipoproteins. XI. The effect of the apolipoprotein C-11 polymorphism on lipoprotein levels in Nigerian blacks. Sepehmia B, Kamboh MI, Adams-Campbell LL, Bunker CH, Majumder PP NM, Ferrel RE, J Lipid Res 1989 30 1349 1355 2600540 (Pubitemid 19253286)
39. High frequency of the apo epsilon 4 allele in Khoi San from South Africa. Sandholzer C, Delport R, Vermaak H, Utermann G, Hum Genet 1995 95 1 46 8 7814025
40. Worldwide distribution of a common MethylenetetrahydrofolateReductase mutation (letter). Schneider JA, Rees DC, Liu Y, Clegg JB, Am J Hum Genet 1998 62 1258 1260 10.1086/301836 9545406 (Pubitemid 28199029)
41. Genotype frequencies and linkage disequilibrium in the CEPH human diversity panel for variants in folate pathway genes MTHFR, MTHFD, MTRR, RFC1, and GCP2. Shi M, Caprau D, Romitti P, Christensen K, Murray Jeffrey C, Birth Defects Res (Part A) 2003 67 545 549 10.1002/bdra.10076 (Pubitemid 37247668)
42. Methylenetetrahydrofolatereductase (MTHFR) from Mediterranean to sub-Saharan areas. Chillemi R, Angius A, Persico I, Sassu A, Prodi DA, Simpore J, Musumeci S, Online J Biol Sci 2005 6 1 28 34
43. Prevalence of methylenetetrahydrofolatereductase677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. Guéant-Rodriguez RM, Guéant JL, Debard R, Thirion S, Xiao Hong L, Bronowicki JP, Namour F, Chabi NW, Sanni A, Anello G, Bosco P, Romano C, Amouzou E, Heidy RA, BE S n, Romano A, Herbeth B, Guilland JC, Mutchinick OM, Am J Clin Nutr 2006 83 701 7 16522920 (Pubitemid 44699219)
44. The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in Whites, Japanese, and Africans. Rosenberg N, Murata M, Ikeda Y, Opare-Sem O, Zivelin A, Geffen E, Seligsohn U, Am J Hum Genet 2002 70 758 762 10.1086/338932 11781870 (Pubitemid 34177929)
45. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Botto LD, Yang Q, Am J Epidemiol 2004 151 9
46. APOE, MTHFR, LDLR and ACE polymorphisms among Angami and Lotha Naga populations of Nagaland, India. Murry B, Vakha N, Achoubi N, Sachdeva MP, Saraswathy KN, J Community Health 2011 36 975 985 10.1007/s10900-011-9397-z 21461956
47. Alu insertion polymorphisms in NW Africa and the Iberian peninsula: evidence for a strong genetic boundary through the Gibraltar Straits. Comas D, Calafell F, Benchemsi N, Helal A, Lefranc G, Stoneking M, Batzer MA, Betranpetit J, Sajantila A, Hum Gen 2000 107 312 319 10.1007/s004390000370
48. Angiotensin gene converting enzyme insertion/deletion polymorphism: association with ethnic origin. Barley J, Blackwood A, Carter ND, Crews DE, Cruickshank JK, Jeffery S, Ogunlesi AO, Sagnella GA, J Hypertens 1994 12 955 957 7814855 (Pubitemid 24283380)
49. Insertion-deletion polymorphism in the angiotensin-converting enzyme (Ace) gene among Sudanese, Somalis, Emiratis, and Omanis. Bayoumi RA, Simsek M, Yahya TM, Bendict S, Alhinai A, Al-Barwani H, Hassan MO, Hum Biol 2006 78 103 108 10.1353/hub.2006.0022 16900885 (Pubitemid 44087150)
50. Deletion polymorphism in the angiotensinconverting enzyme gene is not associated with hypertension in a Gulf Arab population. Frossard PM, Obineche EN, Elshahat YI, Lestringant GG, Clin Genet 1997 51 211 213 9137889 (Pubitemid 27168391)
51. Angiotensin converting enzyme gene polymorphism is not related to essential hypertension in a Greek population. Vassilikioti S, Doumas M, Douma S, Petidis K, Karagiannis A, Balaska K, Am J Hypertens 1996 9 700 702 10.1016/0895-7061(95)00449-1 8806984 (Pubitemid 26266610)
52. Polymorphisms of the renin-angiotensin system genes in Brazilian patients with lupus nephropathy. Sprovieri SR, Sens YA, Lupus 2005 14 356 362 10.1191/0961203305lu2093oa 15934435 (Pubitemid 40756444)
53. Distribution of angiotensin converting enzyme gene polymorphism among Northem Hans, Dahurs, and Ewenks. Zhang YM, Zhang LY, Wang KQ, Acta Pharmacol Sin 2001 22 747 750 11749850
54. Deletion polymorphism in the gene for angiotensinconverting enzyme is a potent risk factor for myocardial infarction. Mohan KR, Julian FR, Michael JK, Nature 1992 359 641 644 10.1038/359641a0 1328889
55. Lack of association of angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism with CAD in two Asian populations. Saha N, Talmud PJ, Tay JSH, Humphries SE, Basair J, Clin Genet 1996 50 121 125 8946109 (Pubitemid 26377577)
56. Angiotensin-converting enzyme gene polymorphism in haemodialysis patients. Nomura H, Koni I, Michishita Y, Morise T, Takeda R, Lancet 1994 343 482 483 (Pubitemid 24059607)
57. Population genetics of the angiotensin-converting enzyme in Chinese. Lee EJD, Br J Clin Pharmacol 1994 37 212 214 10.1111/j.1365-2125.1994.tb04264.x 8186067 (Pubitemid 24213766)
58. The angiotensin-I converting enzyme (ACE) gene I/D polymorphism and ACE levels in Pima Indians. Foy CA, McCormack LJ, Knowler WC, Barrett JH, Catto A, Med Genet 1996 33 336 337 10.1136/jmg.33.4.336 (Pubitemid 26102464)
59. Angiotensin-converting enzyme gene (ACE) insertion/deletion polymorphism in Mexican populations. Vargas-Alarcon G, Hemandez-Pacheco G, Rodriguez-Perez JM, Cardoso G, Posadas-Romero C, Hum Bi Bahnisch J, Bannister K, Faull R, Clarkson Aol 2003 75 889 896 (Pubitemid 38233775)
60. The DD genotype of the angiotensin-converting enzyme gene occurs in very low frequency in Australian Aboriginals. Lester S, Heatley S, Bardy P, Bahnisch J, Bannister K, Faull R, Clarkson A, Nephrol Dial Transplant 1999 14 887 890 10.1093/ndt/14.4.887 10328464 (Pubitemid 29155141)
61. African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Campbell MC, Tishkoff SA, Annu Rev Genomics Hum Genet 2008 9 403 433 10.1146/annurev.genom.9.081307.164258 18593304
62. Genetic Structure in African populations: implications for human demographic history. Lambert CA, Tishkoff SA, Cold Spring Harb Symp Quant Biol 2009 74 395 402 10.1101/sqb.2009.74.053 20453204
63. The apolipoprotein polymorphism in Greenland Inuit in its global perspective. Gerdes LU, Gerdes C, Hansen PS, Klausen IC, Faergeman O, Dyerberg J, Hum Genet 1996 98 5 546 550 10.1007/s004390050257 8882873 (Pubitemid 26394833)
64. Ehret C, An African classical age: Eastern and Southern Africa in world history, 1000 BC to AD 400 Charlottesville: University of Virginia Press 1998
65. Analysis of the 677C→ T mutation of the methylenetatrahydrofolatereductase gene in different ethnic groups. Franco RF, Araujo AG, Guerreiro JF, Elion J, Zago MA, Thromb Haemost 1998 79 119 121 9459335 (Pubitemid 28037069)
66. Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase. (Letter). Pepe G, Camacho Vanegas O, Giusti B, Brunelli T, Marcucci R, Attanasio M, Rickards O, De Stefano GF, Prisco D, Gensini GF, Abbate R, Am J Hum Genet 1998 63 917 20 10.1086/302015 9718345 (Pubitemid 30422697)
67. Cobalamine and folate deficiency: acquired and hereditary disorders in children. Rosenblatt DS, Whitehead VM, Semin Hematol 1999 36 19 34 (Pubitemid 29048610)
68. Hyperhomocysteinemia in acute Plasmodium falciparum malaria: an effect of host-parasite interaction. Chillemi R, Zappacosta B, Simpore J, Persichilli S, Musumeci M, Musumeci S, Clin Chim Acta 2004 348 1-2 113 20 15369744 (Pubitemid 39209009)
69. Preliminary evidence for genetic selection of 677T-MTHFR by natural annual cycle of folate abundance. Lucock M, Yates Z, Ng X, Veysey M, Blades B, Travers C, Lewis P, Sturm J, Roach P, J Nutrigenet Nutrigenomics 2008 1 24 29 10.1159/000109872 19918112 (Pubitemid 350032088)
70. Patterns of human diversity, within and among continents, inferred from biallelic DNA polymorphisms. Romualdi C, Balding D, Nasidze IS, Risch G, Robichaux M, Sherry ST, Barbujani G, Genome Res 2002 12 602 612 10.1101/gr.214902 11932244 (Pubitemid 34308639)
71. Genetic variability in the renin-angiotensin system: prevalence of alleles and genotypes. Staessen JA, Ginocchio G, Wang JG, Saavedra AP, Soubrier F, Vlietnick R, Fagard R, J Cardiovasc Risk 1997 4 401 422 10.1097/00043798- 199710000-00013 9865673 (Pubitemid 28078684)
72. The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition. Harrap SB, Tzourio C, Cambien F, Poirier O, Raoux S, Chalmers J, Chapman N, Colman S, Leguennec S, MacMahon S, Neal B, Ohkubo T, Woodward M, PROGRESS Collaborative Group, Hypertension 2003 42 297 303 10.1161/01.HYP.0000088322.85804.96 12925557 (Pubitemid 37093476)
73. Angiotensin converting enzyme gene polymorphism and its association with essential hypertension in a Tibetian population. Gesang L, Liu G, Cen W, Qiu C, Zhouma C, Zhuang L, Ren D, Pincuo Z, Chan Y, Hypertens Res 2002 25 481 485 10.1291/hypres.25.481 12135330 (Pubitemid 34752570)
74. Progression of left ventricular hypertrophy and the angiotensin- converting enzyme gene polymorphism in hypertrophiccardiomyopathy. Doolan G, Nguyen L, Chung J, Ingles J, Semsarian C, Int J Cardiol 2004 96 157 163 10.1016/j.ijcard.2004.05.003 15314809 (Pubitemid 38979893)
75. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects. Schut AFC, Bleumink GS, Stricker BH, Hofman A, Witteman JCM, Pols HAP, Deckers JW, Deinum J, van Duijn CM, Eur Heart J 2004 25 2143 2148 10.1016/j.ehj.2004.08.026 15571830 (Pubitemid 39572247)
76. Association studies of genetic polymorphism, environmental factors and their interaction in ischemic stroke. Gao XG, Huo Y, Teng ZP, Neurosci Lett 2006 398 172 177 10.1016/j.neulet.2005.12.078 16443328 (Pubitemid 43673708)
77. Genetic background of left ventricular hypertrophy in Uzbek hypertensive men. Kurbanova D, Eliseyeva M, Soc Cardiol 2010 38 466 472
78. Angiotensin-converting enzyme gene and diabetes mellitus. Kennon B, Petrie JR, Small M, Connell JMC, Diabet Med 1999 16 448 458 10.1046/j.1464-5491. 1999.00071.x 10391391